Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial

BACKGROUND: This study evaluated the efficacy and safety of irinotecan/cisplatin (IP) and etoposide/cisplatin (EP) in extensive-stage small cell lung cancer (ES-SCLC) and the distribution of uridine diphosphate glucuronosyltransferase (UGT1A1). The relationship between UGT1A1 genotypes and patient o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yuankai, Hu, Yi, Hu, Xingsheng, Li, Xue, Lin, Lin, Han, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632933/
https://www.ncbi.nlm.nih.gov/pubmed/26557919
http://dx.doi.org/10.1111/1759-7714.12303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632933/
https://www.ncbi.nlm.nih.gov/pubmed/26557919
http://dx.doi.org/10.1111/1759-7714.12303

Ejemplares similares